Dr. William Paul Nobis, MD, PhD

Dr. Nobis practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Nobis' NPI, 1750677647, was assigned on June 20, 2011. Dr. Nobis graduated from Vanderbilt University School of Medicine in 2011. Dr. Nobis holds Tennessee license 57826.

Dr. Nobis' primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Nobis' primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Nobis is also affiliated with Vanderbilt Tullahoma-Harton Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Nobis to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nobis practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Nobis' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Nobis' licenses on file in 2 states: Tennessee and Illinois.

CMS data shows 466 Medicare services from Dr. Nobis across 5 procedure codes in 2024, for 80 Medicare patients. Medicare paid $17,031 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Nobis in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nobis' median patient age at 59, with 56% women.

In 2024, Dr. Nobis wrote 583 Medicare Part D claims for 67 patients. 85% of them were for generic drugs. CMS names the drug for 498 of them, across 11 drugs with 11 or more claims each, at $94,813 in total drug cost. In 2023, CMS named 465 claims across 12 drugs.

Dr. Nobis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nobis as offering telehealth.

Dmand AI links 15 papers to Dr. Nobis, published from 2017 to 2024. 2022 was the busiest year, with 4. The most frequent topics are Electroencephalography, Mice, Inbred C57BL and Synaptic Transmission. Dr. Nobis has published most often in eNeuro. Dr. Nobis' most frequent co-authors are Bassel Abou-Khalil, MD, Martin J. Gallagher, MD, PhD and Jonah Fox, MD.

CMS Open Payments shows 6 general payments to Dr. Nobis from 2 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 67% of the total. Neuropace, Inc. paid the most, $1,188.

Dr. Nobis graduated from Vanderbilt University School of Medicine in 2011.